Issue Open Date
|
09-Nov-20
|
Issue Closing Date
|
11-Nov-20
|
Application Money
|
100
|
Allotment Money
|
|
|
Price Band (Rs.)
|
1490-1500
|
Minimum Bid Quantity.
|
10
|
Issue Size (Shares)
|
30237879
|
Market Lot
|
1
|
|
|
Objective :
|
To finance the incremental working capital requirements of our CompanyTo meet funding requirements for capital expenditure requirementsTo meet the general corporate purposes
|
|
|
|
Category
|
No. of Shares
|
No. of Shares
|
Subscription Ratio
|
|
Offered / Reserved
|
Bid For
|
|
Non-Institutional Investors
|
6479546
|
3294470
|
0.51
|
Qualified Institutional Buyers
|
8639394
|
55250350
|
6.4
|
Retail Individual Investors
|
8639394
|
55250350
|
6.4
|
|
|
|
Business Description
|
|
Promoter's Holding
|
Total Share Capital
|
114662620
|
Offered to Public
|
43196968
|
Promoter's Holding (Pre-Issue)
|
74
|
Promoter's Holding (Post-Issue)
|
70.22
|
|
|
|
|
|
|
Address
|
Survey No. 143-148 150 & 151 Near Gandimaisamma 'x' Roads D. P. Pally Dundigal Gandimaisamma Mandal Medchal- Malkajgiri District
Hyderabad
,
Telangana
,
500043
Phone :
040 30510999
Email :
gland@glandpharma.com / investor@glandpharma.com
Website :
www.glandpharma.com
|
|
Registrar
|
Link Intime India Pvt Ltd.
C 101 247 Park LBS Marg Vikhroli (West) Mumbai
|
|
Listed at
|
BSE, NSE
|
|
Lead Manager
|
Citigroup Global Markets India Pvt Ltd. Haitong Securities India Pvt Ltd. Kotak Mahindra Capital Co Ltd Nomura Financial Advisory & Securities (India) Pvt Ltd.
|
|
Promoters
|
Fosun Pharma Industrial Pte. Ltd. Shanghai Fosun Pharmaceutical (Group) Co. Ltd.
|
|